Rating History for GlaxoSmithKline (GSK) by Barclays

More Stocks Rated by Barclays | Latest Ratings for GSK
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/6/2026 James Gordon Downgrade Underweight
(Equalweight)		 N/A
(N/A)		 49.02
(54.51)		 11.2% Details